MAM
Omnicom expands global solutions presence with new Hyderabad campus
MUMBAI: Data-inspired, creative marketing and sales solutions provider Omnicom is getting omnipresent in India. It has announced the opening of its latest global solutions campus in Hyderabad, following the launch of facilities in Bengaluru, Chennai, and Gurugram in April 2024. This strategic expansion underscores the company’s commitment to leveraging India’s vast talent pool and driving innovation to enhance client services globally.
The Hyderabad campus will bolster Omnicom’s global client solutions capabilities, offering expertise in media, technology, digital commerce, marketing science, market research, creative services, and business support functions.
Annalect India & Omnicom Global Solutions CEO Vishal Srivastava highlighted the importance of the new campus, stating: “This state-of-the-art collaboration hub will be a convergence point for brilliant minds, revolutionising the marketing landscape through innovation and excellence.”
Credera India GDC CEO Gaurav Mathur added: “Hyderabad’s dynamic ecosystem and skilled workforce will further strengthen our ability to deliver transformative solutions for clients worldwide.”
The four Indian campuses now host over 5,500 professionals across media, data and analytics, creative services, marketing technology, digital commerce, and artificial intelligence. The newly designed facilities provide collaborative work environments aimed at empowering Omnicom agencies globally and driving client value.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
